使用以人为中心的设计和开发来创建一个数字的病日药物指导应用程序,用于糖尿病患者,心血管疾病或慢性病患者:混合方法研究研究
Julie Babione1, Sarah Gil1, Chidera Okemeziem1
1Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
JMIR formative research
|November 27, 2025
概括
一个新的数字应用程序,PAUSE,帮助患有糖尿病,心脏和脏疾病的患者在疾病期间管理药物. 这个病日药物指导 (SDMG) 工具旨在通过提供个性化的自我管理支持,防止紧急访问和住院.
科学领域:
- 数字健康干预措施 数字健康干预措施
- 患者的自我管理.
- 慢性疾病管理 慢性疾病管理
背景情况:
- 糖尿病,心血管疾病和慢性病 (CKD) 与高发病率和医疗费用有关.
- 治疗这些疾病的药物可能会导致并发症,如低血糖症和急性损伤在急性疾病期间.
- 缺乏有效的策略来提供病假药物指导 (SDMG) 以预防不良事件.
研究的目的:
- 代设计和开发用于SDMG交付的数字原型用户界面 (UI).
- 创建 PAUSE 应用程序,以便在急性疾病期间个性化患者自行管理药物.
- 通过加强药物自我管理,减少急诊和住院.
主要方法:
- 使用以人为中心的设计 (HCD) 方法,涉及代启发性评估和可用性测试.
- 原型的修订是基于既定的UI标准和主观患者反.
- 数据分析以演和务实的方式进行,以告知快速代.
主要成果:
- 通过启发式评估确定了21个设计问题,通过可用性测试确定了44个问题.
- 开发团队反复修改了PAUSE UI原型.
- 最终的设计包括用户流和提醒在急性疾病期间暂停药物.
结论:
- 一种代的HCD方法成功地产生了一个精致的SDMG自我管理原型.
- PAUSE应用程序是为糖尿病,心血管疾病和CKD患者设计的.
- 需要进一步的研究来评估应用程序的有效性和整合到慢性疾病的护理.
相关概念视频
01:18Chronic Kidney Disease IV: Nursing Management
299
Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
299
01:28Chronic Kidney Disease III: Interprofessional Care
323
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
323
01:28Dosage Regimens: Designs and Approaches
242
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
242
01:15Bioavailability Study Design: Healthy Subjects Versus Patients
135
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
135